cst and pgl: 2 gravy trains running?, page-2

cst is not a 2 gravy trains running? CST with it's current pricing and no approval is the highest risk it has been since just prior to it's original approval yeays ago. The price has run up in expectation that there will be FDA approval and new documentation and subsequent sales. Realistically this only gets the test into the USA with defacto approval in Europe which may currently total 15 million tests if it was adopted instantly. Japan may be 30 mill tests but it is a seperate approval process and may and may have time to go yet.

This is a high risk time for CST as current trader interest may fade if it doesn't run hard and hold gains. With expectations of further approvals and intstant sales.

I am hopefull but then again I didn't enter at these prices so I have a good buffer should I wish to ride out the volatility and go for the bigger market later.

Nice bit of marketing for PGL - is that being pumped?